21 CFR Part 524
PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
- PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
- Chapter I—Food and Drug Administration, Department of Health and Human Services › Subchapter E—Animal Drugs, Feeds, and Related Products
- § 524.86 Amitraz.
- § 524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
- § 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
- § 524.230 Buprenorphine.
- § 524.390 Chloramphenicol ophthalmic ointment.
- § 524.402 Chlorhexidine.
- § 524.450 Clotrimazole.
- § 524.463 Copper naphthenate.
- § 524.575 Cyclosporine ophthalmic ointment.
- § 524.590 Diclofenac.
- § 524.660 Dimethyl sulfoxide.
- § 524.770 Doramectin.
- § 524.775 Emodepside and praziquantel.
- § 524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
- § 524.814 Eprinomectin.
- § 524.815 Eprinomectin and praziquantel.
- § 524.838 Esafoxolaner, eprinomectin, and praziquantel.
- § 524.900 Famphur.
- § 524.920 Fenthion.
- § 524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
- § 524.957 Florfenicol, terbinafine, and mometasone otic solution.
- § 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
- § 524.970 Flunixin.
- Fluocinolone Topical and Otic Dosage Forms
- § 524.981 [Reserved]
- § 524.981a Fluocinolone cream.
- § 524.981b Fluocinolone solution.
- § 524.981c Fluocinolone and neomycin cream.
- § 524.981d Fluocinolone and dimethyl sulfoxide solution.
- § 524.981e Fluocinolone and dimethyl sulfoxide otic solution.
- § 524.998 Fluralaner.
- § 524.1001 Fluralaner and moxidectin.
- § 524.1005 Furazolidone powder.
- § 524.1044 Gentamicin ophthalmic and topical dosage forms.
- § 524.1044a Gentamicin ophthalmic solution.
- § 524.1044b Gentamicin and betamethasone otic solution.
- § 524.1044c Gentamicin ophthalmic ointment.
- § 524.1044d Gentamicin and betamethasone ointment.
- § 524.1044e Gentamicin spray.
- § 524.1044f Gentamicin and betamethasone spray.
- § 524.1044g Gentamicin, betamethasone, and clotrimazole ointment.
- § 524.1044h Gentamicin, mometasone, and clotrimazole otic suspension.
- § 524.1044i Gentamicin and betamethasone ophthalmic solution.
- § 524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.
- § 524.1140 Imidacloprid and ivermectin.
- § 524.1144j Gentamicin, posaconazole, and mometasone furoate otic suspension.
- § 524.1146 Imidacloprid and moxidectin.
- § 524.1193 Ivermectin topical solution.
- § 524.1195 Ivermectin otic suspension.
- § 524.1200 Kanamycin ophthalmic and topical dosage forms.
- § 524.1200a Kanamycin ophthalmic ointment.
- § 524.1200b Kanamycin ophthalmic solution.
- § 524.1204 Kanamycin, amphomycin, and hydrocortisone ointment.
- § 524.1240 Levamisole.
- § 524.1312 Marbofloxacin, terbinafine, and dexamethasone otic suspension.
- § 524.1376 2-Mercaptobenzothiazole solution.
- § 524.1443 Miconazole.
- § 524.1445 Miconazole, polymixin B, and prednisolone suspension.
- § 524.1446 Milbemycin otic solution.
- § 524.1448 Mirtazapine transdermal ointment.
- § 524.1450 Moxidectin.
- § 524.1465 Mupirocin.
- § 524.1484 Neomycin ophthalmic and topical dosage forms.
- § 524.1484b Neomycin, isoflupredone, and tetracaine powder.
- § 524.1484c Neomycin, isoflupredone, and tetracaine ointment.
- § 524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.
- § 524.1484e Neomycin and polymyxin B ophthalmic solution.
- § 524.1484f Neomycin, prednisolone, and tetracaine otic suspension.
- § 524.1484g Neomycin, thiabendazole, and dexamethasone solution.
- § 524.1484h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
- § 524.1484i Neomycin and hydrocortisone ointment.
- § 524.1484k Neomycin and prednisolone suspension.
- § 524.1580 Nitrofurazone topical dosage forms.
- § 524.1580a Nitrofurazone ointment.
- § 524.1580b Nitrofurazone soluble powder.
- § 524.1600 Nystatin ophthalmic and topical dosage forms.
- § 524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
- § 524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
- § 524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
- § 524.1662 Oxytetracycline ophthalmic and topical dosage forms.
- § 524.1662a Oxytetracycline and hydrocortisone spray.
- § 524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
- § 524.1742 Phosmet emulsifiable liquid.
- § 524.1982 Proparacaine ophthalmic solution.
- § 524.2080 Ropinirole.
- § 524.2098 Selamectin.
- § 524.2099 Selamectin and sarolaner.
- § 524.2101 Selenium disulfide suspension.
- § 524.2338 Terbinafine and betamethasone acetate.
- § 524.2350 Tolnaftate cream.
- § 524.2482 Triamcinolone spray.
- § 524.2620 Liquid crystalline trypsin, Peru balsam, castor oil.
Feedback